A Clinical Trial to study the effect of the Drug Karpoora silasathu parpam in patients with kidney stones

A clinical study on kalladaippu (Urolithiasis) with the evaluation of siddha drug " Karpoora silasathu parpam "

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/04/008435

Enrollment

Registered

2017-04-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Kalladaippu (Urolithiasis)

Interventions

Intervention1: Karpoora Silasthu Parpam: 130 mg with Ilaneer,48 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: 1.History of Urolithiasis (with USG-Whole Abdomen reports) 2.Pain the Flank 3.Burning Micturition 4.Nausea 5.Vomiting 6.Oliguria 7.Dysuria 8.Haematuria 9.Fever 10.Stone size-4 to 10mm

Exclusion criteria

Exclusion criteria: 1.Hydro nephrosis 2.Stag horn calculus 3.Calculi associated with elevated serum creatinine level 4.Calculi in pregnancy

Design outcomes

Primary

Measure	Time frame
Mainly assessed by reduction of clinical symptoms and comparing before and after treatmentTimepoint: 48 days	—

Secondary

Measure	Time frame
Any toxicity of the drugTimepoint: 14 days	—

Countries

India

Contacts

Public ContactDr S Sarathkumar

Govt.siddha medical college

dr.kkanakavalli@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026